{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:45:41Z","timestamp":1769924741732,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11096-020-01212-z","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T02:40:10Z","timestamp":1610592010000},"page":"1036-1044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gender differences in the adverse events associated with cardiovascular drugs in a spontaneous reporting system in South Korea"],"prefix":"10.1007","volume":"43","author":[{"given":"Han-Heui","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"8","key":"1212_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/eurheartj\/ehi819.","volume":"27","author":"M Stramba-Badiale","year":"2006","unstructured":"Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J. 2006;27(8):994\u20131005. https:\/\/doi.org\/10.1093\/eurheartj\/ehi819.","journal-title":"Eur Heart J"},{"issue":"2","key":"1212_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.15268\/ksim.2016.4.2.097.","volume":"4","author":"Y Bae","year":"2016","unstructured":"Bae Y, Lee K. Risk Factors for Cardiovascular Disease in Adults Aged 30 Years and Older. J Korean Soc Integr Med. 2016;4(2):97\u2013107. https:\/\/doi.org\/10.15268\/ksim.2016.4.2.097.","journal-title":"J Korean Soc Integr Med"},{"issue":"3","key":"1212_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042.","volume":"3","author":"J Tamargo","year":"2017","unstructured":"Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, et al. Gender differences in the effects of cardiovascular drugs. Eur Heart J Cardiovasc Pharmacother. 2017;3(3):163\u201382. https:\/\/doi.org\/10.1093\/ehjcvp\/pvw042.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"1212_CR4","doi-asserted-by":"publisher","first-page":"e63347","DOI":"10.1371\/journal.pone.0063347.","volume":"8","author":"TS Mikkola","year":"2013","unstructured":"Mikkola TS, Gissler M, Merikukka M, Tuomikoski P, Ylikorkala O. Sex differences in age-related cardiovascular mortality. PLoS ONE. 2013;8(5):e63347. https:\/\/doi.org\/10.1371\/journal.pone.0063347.","journal-title":"PLoS ONE"},{"issue":"3","key":"1212_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4069\/kjwhn.2010.16.3.224.","volume":"16","author":"H So","year":"2010","unstructured":"So H, Ahn S, Song R, Kim H. Relationships among obesity, bone mineral density, and cardiovascular risks in post-menopausal women. Korean J Women Health Nurs. 2010;16(3):224\u201333. https:\/\/doi.org\/10.4069\/kjwhn.2010.16.3.224.","journal-title":"Korean J Women Health Nurs."},{"issue":"8","key":"1212_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.metabol.2006.03.018.","volume":"55","author":"YA Shakir","year":"2006","unstructured":"Shakir YA, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C. Does the hormonal situation modify lipid effects by lifestyle factors in middle-aged women? Results from a population-based study of Swedish women: the women\u2019s health in the Lund area study. Metabolism. 2006;55(8):1060\u20136. https:\/\/doi.org\/10.1016\/j.metabol.2006.03.018.","journal-title":"Metabolism"},{"issue":"5","key":"1212_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/01.gme.0b013e318166904e.","volume":"15","author":"KE Innes","year":"2008","unstructured":"Innes KE, Selfe TK, Taylor AG. Menopause, the metabolic syndrome, and mind-body therapies. Menopause. 2008;15(5):1005\u201313. https:\/\/doi.org\/10.1097\/01.gme.0b013e318166904e.","journal-title":"Menopause"},{"issue":"5","key":"1212_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x.","volume":"46","author":"RM Martin","year":"1998","unstructured":"Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol. 1998;46(5):505\u201311. https:\/\/doi.org\/10.1046\/j.1365-2125.1998.00817.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1212_CR9","doi-asserted-by":"publisher","first-page":"24955","DOI":"10.1038\/srep24955.","volume":"6","author":"Y Yu","year":"2016","unstructured":"Yu Y, Chen J, Li D, Wang L, Wang W, Liu H. Systematic analysis of adverse event reports for sex differences in adverse drug events. Sci Rep. 2016;6:24955. https:\/\/doi.org\/10.1038\/srep24955.","journal-title":"Sci Rep"},{"key":"1212_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/B978-0-12-803506-1.00059-0","volume-title":"Principles of Gender-Specific Medicine","author":"I S\u00e1nchez-Serrano","year":"2017","unstructured":"S\u00e1nchez-Serrano I. Chapter 50-Gender-Specific Medicine in Pharmaceutical Drug Discovery and Development. In: Legato MJ, editor. Principles of Gender-Specific Medicine. 3rd ed. San Diego: Academic Press; 2017. p. 733- 741.","edition":"3"},{"issue":"4","key":"1212_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1586\/ecp.11.29.","volume":"4","author":"A Parekh","year":"2014","unstructured":"Parekh A, Fadiran EO, Uhl K, Throckmorton DC. Adverse effects in women: implications for drug development and regulatory policies. Expert Review Clinic Pharmacol. 2014;4(4):453\u201366. https:\/\/doi.org\/10.1586\/ecp.11.29.","journal-title":"Expert Review Clinic Pharmacol"},{"issue":"1","key":"1212_CR12","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.18549\/PharmPract.2016.01.708.","volume":"14","author":"KA Liu","year":"2016","unstructured":"Liu KA, DiPietro Mager NA. Women\u2019s involvement in clinical trials: historical perspective and future implications. Pharmacy Practice. 2016;14(1):1886\u20133655. https:\/\/doi.org\/10.18549\/PharmPract.2016.01.708.","journal-title":"Pharmacy Practice."},{"issue":"7","key":"1212_CR13","doi-asserted-by":"publisher","first-page":"e196700","DOI":"10.1001\/jamanetworkopen.2019.6700.","volume":"2","author":"S Feldman","year":"2019","unstructured":"Feldman S, Ammar W, Lo K, Trepman E, van Zuylen M, Etzioni O. Quantifying sex bias in clinical studies at scale with automated data extraction. JAMA Netw Open. 2019;2(7):e196700. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.6700.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1212_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","volume":"11","author":"I Zucker","year":"2020","unstructured":"Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11(1):32. https:\/\/doi.org\/10.1186\/s13293-020-00308-5.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"1212_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143\u201357. https:\/\/doi.org\/10.2165\/00003088-200948030-00001.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1212_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/clpt.2012.233","volume":"93","author":"G Koren","year":"2012","unstructured":"Koren G, Nordeng H, MacLeod S. Gender differences in drug bioequivalence: time to rethink practices. Clin Pharmacol Ther. 2012;93(3):260\u20132. https:\/\/doi.org\/10.1038\/clpt.2012.233.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"1212_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","volume":"64","author":"Y Zopf","year":"2008","unstructured":"Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008;64(10):999\u20131004. https:\/\/doi.org\/10.1007\/s00228-008-0494-6.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1212_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/bcp.13923","volume":"85","author":"ST de Vries","year":"2019","unstructured":"de Vries ST, Denig P, Ekhart C, Burgers JS, Kleefstra N, Mol PGM, et al. Sex differences in adverse drug reactions reported to the national pharmacovigilance centre in the netherlands: an explorative observational study. Br J Clin Pharmacol. 2019;85(7):1507\u201315. https:\/\/doi.org\/10.1111\/bcp.13923.","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"1212_CR19","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1016\/j.vaccine.2017.03.035","volume":"35","author":"T Harris","year":"2017","unstructured":"Harris T, Nair J, Fediurek J, Deeks SL. Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012\u201315. Vaccine. 2017;35(19):2600\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.035.","journal-title":"Vaccine"},{"issue":"9","key":"1212_CR20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00228-018-2480-y","volume":"74","author":"DM Rydberg","year":"2018","unstructured":"Rydberg DM, Mejyr S, Loikas D, Schenck-Gustafsson K, von Euler M, Malmstrom RE. Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs. Eur J Clin Pharmacol. 2018;74(9):1165\u201373. https:\/\/doi.org\/10.1007\/s00228-018-2480-y.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1212_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3961\/jpmph.2007.40.4.278","volume":"40","author":"NK Choi","year":"2007","unstructured":"Choi NK, Park BJ. Adverse drug reaction surveillance system in Korea. J Prev Med Public Health. 2007;40(4):278\u201384. https:\/\/doi.org\/10.3961\/jpmph.2007.40.4.278.","journal-title":"J Prev Med Public Health"},{"issue":"5","key":"1212_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS. Towards Actualizing the value potential of korea health insurance review and assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718\u201328. https:\/\/doi.org\/10.3346\/jkms.2017.32.5.718.","journal-title":"J Korean Med Sci"},{"issue":"23","key":"1212_CR23","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.3346\/jkms.2018.33.e163","volume":"33","author":"YJ Ko","year":"2018","unstructured":"Ko YJ, Kim S, Park K, Kim M, Yang BR, Kim MS, et al. Impact of the health insurance coverage policy on oral anticoagulant prescription among patients with atrial fibrillation in Korea from 2014 to 2016. J Korean Med Sci. 2018;33(23):e163. https:\/\/doi.org\/10.3346\/jkms.2018.33.e163.","journal-title":"J Korean Med Sci"},{"key":"1212_CR24","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.2147\/DDDT.S97088","volume":"10","author":"D Colombo","year":"2016","unstructured":"Colombo D, Zagni E, Nica M, Rizzoli S, Ori A, Bellia G. Gender differences in the adverse events\u2019 profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis. Drug Des Devel Ther. 2016;10:2917\u201327. https:\/\/doi.org\/10.2147\/DDDT.S97088.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"1212_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1472-8206.2002.00100.x","volume":"16","author":"JL Montastruc","year":"2002","unstructured":"Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol. 2002;16(5):343\u20136. https:\/\/doi.org\/10.1046\/j.1472-8206.2002.00100.x.","journal-title":"Fundam Clin Pharmacol"},{"issue":"40","key":"1212_CR26","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","volume":"36","author":"GM Rosano","year":"2015","unstructured":"Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, et al. Gender differences in the effect of cardiovascular drugs: a position document of the working group on pharmacology and drug therapy of the ESC. Eur Heart J. 2015;36(40):2677\u201380. https:\/\/doi.org\/10.1093\/eurheartj\/ehv161.","journal-title":"Eur Heart J"},{"issue":"1","key":"1212_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2012.07.003","volume":"38","author":"D Fairweather","year":"2013","unstructured":"Fairweather D, Cooper LT Jr, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7\u201346. https:\/\/doi.org\/10.1016\/j.cpcardiol.2012.07.003.","journal-title":"Curr Probl Cardiol"},{"key":"1212_CR28","doi-asserted-by":"publisher","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al (1996). The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med.334 (21):1349\u20131355 https:\/\/doi.org\/10.1056\/NEJM199605233342101.","DOI":"10.1056\/NEJM199605233342101"},{"issue":"1","key":"1212_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000350961","volume":"126","author":"VL Serebruany","year":"2013","unstructured":"Serebruany VL, Dinicolantonio JJ, Can MM, Pershukov IV, Kuliczkowski W. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive. Cardiology. 2013;126(1):35\u201340. https:\/\/doi.org\/10.1159\/000350961.","journal-title":"Cardiology"},{"issue":"4","key":"1212_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ccd.26606","volume":"89","author":"J Chandrasekhar","year":"2017","unstructured":"Chandrasekhar J, Baber U, Sartori S, Faggioni M, Aquino M, Kini A, et al. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: results from the PROMETHEUS study. Catheter Cardiovasc Interv. 2017;89(4):629\u201337. https:\/\/doi.org\/10.1002\/ccd.26606.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"1212_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2217\/pgs-2017-0070","volume":"18","author":"V Tatarunas","year":"2017","unstructured":"Tatarunas V, Kupstyte N, Zaliunas R, Giedraitiene A, Lesauskaite V. The impact of clinical and genetic factors on ticagrelor and clopidogrel antiplatelet therapy. Pharmacogenomics. 2017;18(10):969\u201379. https:\/\/doi.org\/10.2217\/pgs-2017-0070.","journal-title":"Pharmacogenomics"},{"key":"1212_CR32","doi-asserted-by":"publisher","first-page":"c1768","DOI":"10.1136\/bmj.c1768","volume":"340","author":"L Wei","year":"2010","unstructured":"Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM. Spironolactone use and renal toxicity: population based longitudinal analysis. BMJ. 2010;340:c1768. https:\/\/doi.org\/10.1136\/bmj.c1768.","journal-title":"BMJ"},{"issue":"3","key":"1212_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/bcp.13152","volume":"83","author":"IS Mackenzie","year":"2017","unstructured":"Mackenzie IS, Morant SV, Wei L, Thompson AM, MacDonald TM. Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol. 2017;83(3):653\u201363. https:\/\/doi.org\/10.1111\/bcp.13152.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1212_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/SGA.0000000000000357","volume":"41","author":"M Nguyen","year":"2018","unstructured":"Nguyen M, Malone MM, Bailey A, Lapum J. Women\u2019s Experiences of Intimate Relationships While Living With Irritable Bowel Syndrome. Gastroenterol Nurs. 2018;41(6):516\u201324. https:\/\/doi.org\/10.1097\/SGA.0000000000000357.","journal-title":"Gastroenterol Nurs"},{"issue":"2","key":"1212_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5056\/jnm14116","volume":"21","author":"SP Lee","year":"2015","unstructured":"Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil. 2015;21(2):273\u201382. https:\/\/doi.org\/10.5056\/jnm14116.","journal-title":"J Neurogastroenterol Motil"},{"issue":"6","key":"1212_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-2982.2010.01502.x","volume":"22","author":"T Piche","year":"2010","unstructured":"Piche T, Ducrotte P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6):626-e174. https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01502.x.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"1212_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12328-015-0611-x","volume":"8","author":"Y Sato","year":"2015","unstructured":"Sato Y, Fukudo S. Gastrointestinal symptoms and disorders in patients with eating disorders. Clin J Gastroenterol. 2015;8(5):255\u201363. https:\/\/doi.org\/10.1007\/s12328-015-0611-x.","journal-title":"Clin J Gastroenterol"},{"issue":"3","key":"1212_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5056\/jnm16220","volume":"23","author":"C Lee","year":"2017","unstructured":"Lee C, Doo E, Choi JM, Jang SH, Ryu HS, Lee JY, et al. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil. 2017;23(3):349\u201362. https:\/\/doi.org\/10.5056\/jnm16220.","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"1212_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/jhh.2008.157","volume":"23","author":"A de la Sierra","year":"2009","unstructured":"de la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens. 2009;23(8):503\u201311. https:\/\/doi.org\/10.1038\/jhh.2008.157.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"1212_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1524-6175.2003.02402.x","volume":"5","author":"D Sica","year":"2003","unstructured":"Sica D. Calcium channel blocker-related periperal edema: can it be resolved? J Clin Hypertens. 2003;5(4):291\u20135. https:\/\/doi.org\/10.1111\/j.1524-6175.2003.02402.x.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"1212_CR41","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595\u2013622. https:\/\/doi.org\/10.1210\/jc.2019-00221.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"1212_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.5435\/JAAOS-D-17-00713","volume":"27","author":"K Sutton","year":"2019","unstructured":"Sutton K, Sanft TB, Knobf TM, Ibe IK. Musculoskeletal effects of antineoplastic agents. J Am Acad Orthop Surg. 2019;27(22):834\u20139. https:\/\/doi.org\/10.5435\/JAAOS-D-17-00713.","journal-title":"J Am Acad Orthop Surg"},{"issue":"8","key":"1212_CR43","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/GME.0000000000000317","volume":"21","author":"CL Shufelt","year":"2014","unstructured":"Shufelt CL, Manson JE. American college of C. Statin therapy women Menopause. 2014;21(8):896\u20138. https:\/\/doi.org\/10.1097\/GME.0000000000000317.","journal-title":"Statin therapy women Menopause"},{"issue":"7","key":"1212_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","volume":"158","author":"H Zhang","year":"2013","unstructured":"Zhang H, Plutzky J, Skentzos S, Morrison F, Mar P, Shubina M, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med. 2013;158(7):526\u201334. https:\/\/doi.org\/10.7326\/0003-4819-158-7-201304020-00004.","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01212-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:30:15Z","timestamp":1628537415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01212-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01212-z","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. JY Shin report receipt of research funding from the Ministry of Food and Drug Safety, Ministry of Health and Welfare, and National Research Foundation of Republic of Korea; grants from pharmaceutical companies including Amgen, Pfizer, Hoffmann-La Roche, Dong-A ST, Yungjin outside the submitted work.No other conflict of interests reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}